Gi-Cheol Park
Comptroller/Controller/Auditor at FLASK CO., LTD.
Network origin in Gi-Cheol Park first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Electronic Production Equipment | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gi-Cheol Park via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
GEMVAX&KAEL CO.,LTD. | Industrial Machinery | Chief Executive Officer | |
KAEL-GemVax Co., Ltd.
KAEL-GemVax Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., KAEL-GemVax Co., Ltd. manufactures bio-pharmaceutical products. The company is based in Seongnam, South Korea. The CEOs of the South Korean company are Gyeong Hee Kim, Sang-Jae Kim, Magnus Moliteus. | Pharmaceuticals: Major | Chief Executive Officer | |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Biotechnology | Chief Executive Officer | |
Hanyang University | College/University | Doctorate Degree | |
Gem & Co. /KR/
Gem & Co. /KR/ Investment ManagersFinance Gem & Co. /KR/ engages in the provision of financial consulting and trading services. The company was founded on September 9, 2004 and is headquartered in Seongnam, South Korea. | Investment Managers | Chief Executive Officer | |
Gemvax AS
Gemvax AS Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., Gemvax AS is a Norwegian peptide-based drug development company that focuses on researching and developing treatments for Alzheimer's disease and prostate hyperplasia. The company is based in Porsgrunn, Norway. The company also develops and sell products such as CA filters and provide investment information. The company was founded by Mona Elisabeth Møller. Gemvax was acquired by VaxOnco, Inc. from Pharmexa A/S on October 30, 2008. | Pharmaceuticals: Major | Director/Board Member | |
Gemvax USA, Inc. | Chief Executive Officer | ||
SAMSUNG PHARM. CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
GEMVAXLINK CO., LTD. | Apparel/Footwear Retail | Chief Executive Officer | |
Teloid, Inc. | Chief Executive Officer |
Statistics
International
South Korea | 10 |
United States | 3 |
Norway | 2 |
Sweden | 2 |
Sectoral
Health Technology | 5 |
Electronic Technology | 2 |
Process Industries | 2 |
Producer Manufacturing | 2 |
Consumer Services | 2 |
Operational
Director/Board Member | 15 |
Chief Executive Officer | 12 |
Independent Dir/Board Member | 2 |
President | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Most connected contacts
Insiders | |
---|---|
Sang-Jae Kim | 14 |
In-Sook Kim | 1 |
Seung-Yeon Kim | 1 |
Sung-Jin Park | 1 |
Byung-Jae Lee | 1 |
Soo-Ah Yoon | 1 |
Se-Jun Park | 1 |
Styslinger Sarah | 1 |
- Stock Market
- Insiders
- Gi-Cheol Park
- Company connections